The proto-oncogene transcription factor MYC is often implicated as a central driver gene in AML, wherein MYC amplification is typically seen due to duplications, promoter mutations, or other gene-regulatory shifts, rather than chromosomal rearrangements [16,17,18]. The gene discussed is MYC; the disease is acute myeloid leukemia.